Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 142

    1.

    Nitric oxide-sensitive soluble guanylyl cyclase activity is preserved in internal mammary artery of type 2 diabetic patients.

    Witte K, Hachenberger J, Castell MF, Vahl CF, Haller C.

    Diabetes. 2004 Oct;53(10):2640-4.PMID: 15448095 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.

    Hoenicka M, Becker EM, Apeler H, Sirichoke T, Schröder H, Gerzer R, Stasch JP.

    J Mol Med. 1999 Jan;77(1):14-23.PMID: 9930922 [PubMed - indexed for MEDLINE]Related articles

    3.

    Dysregulation of the endothelial nitric oxide synthase-soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic rat.

    Zanetti M, Barazzoni R, Stebel M, Roder E, Biolo G, Baralle FE, Cattin L, Guarnieri G.

    Atherosclerosis. 2005 Jul;181(1):69-73. Epub 2005 Feb 12.PMID: 15939056 [PubMed - indexed for MEDLINE]Related articles

    4.

    Nitric oxide-dependent soluble guanylate cyclase activity is decreased in platelets from male NIDDM patients.

    Michimata T, Murakami M, Iriuchijima T.

    Life Sci. 1996;59(17):1463-71.PMID: 8890925 [PubMed - indexed for MEDLINE]Related articles

    5.

    Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.

    Bellamy TC, Wood J, Goodwin DA, Garthwaite J.

    Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2928-33.PMID: 10717006 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation.

    Perkins WJ, Kost S, Danielson M.

    Am J Physiol Lung Cell Mol Physiol. 2009 Apr;296(4):L666-73. Epub 2009 Jan 30.PMID: 19181745 [PubMed - indexed for MEDLINE]Related articles

    7.

    Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.

    Zhou Z, Pyriochou A, Kotanidou A, Dalkas G, van Eickels M, Spyroulias G, Roussos C, Papapetropoulos A.

    Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1763-71. Epub 2008 Aug 29.PMID: 18757489 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state.

    Witte K, Jacke K, Stahrenberg R, Arlt G, Reitenbach I, Schilling L, Lemmer B.

    Nitric Oxide. 2002 Feb;6(1):85-95.PMID: 11829539 [PubMed - indexed for MEDLINE]Related articles

    9.

    Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.

    Queen LR, Ji Y, Goubareva I, Ferro A.

    Diabetologia. 2003 Nov;46(11):1474-82. Epub 2003 Oct 23.PMID: 14574451 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice.

    Echeverry MB, Salgado ML, Ferreira FR, da-Silva CA, Del Bel EA.

    Psychopharmacology (Berl). 2007 Oct;194(2):271-8. Epub 2007 Jun 26.PMID: 17593355 [PubMed - indexed for MEDLINE]Related articles

    11.

    Thiol oxidation inhibits nitric oxide-mediated pulmonary artery relaxation and guanylate cyclase stimulation.

    Mingone CJ, Gupte SA, Ali N, Oeckler RA, Wolin MS.

    Am J Physiol Lung Cell Mol Physiol. 2006 Mar;290(3):L549-57. Epub 2005 Nov 4.PMID: 16272175 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cardiovascular effects of modulators of soluble guanylyl cyclase activity.

    Hoenicka M, Schmid C.

    Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):287-301. Review.PMID: 18855642 [PubMed - indexed for MEDLINE]Related articles

    13.

    In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics.

    Artz JD, Toader V, Zavorin SI, Bennett BM, Thatcher GR.

    Biochemistry. 2001 Aug 7;40(31):9256-64.PMID: 11478893 [PubMed - indexed for MEDLINE]Related articles

    14.

    Compromised arterial function in human type 2 diabetic patients.

    Okon EB, Chung AW, Rauniyar P, Padilla E, Tejerina T, McManus BM, Luo H, van Breemen C.

    Diabetes. 2005 Aug;54(8):2415-23.PMID: 16046309 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prolonged relaxation consistent with persistent soluble guanylyl cyclase activation in canine pulmonary artery following brief treatment with nitric oxide donors.

    Kwak YL, Jones KA, Warner DO, Perkins WJ.

    Life Sci. 2006 Oct 19;79(21):2001-9. Epub 2006 Jun 29.PMID: 16854434 [PubMed - indexed for MEDLINE]Related articles

    16.

    Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.

    Nimmegeers S, Sips P, Buys E, Brouckaert P, Van de Voorde J.

    Cardiovasc Res. 2007 Oct 1;76(1):149-59. Epub 2007 Jun 12.PMID: 17610859 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine.

    Ehsan A, Sommer F, Schmidt A, Klotz T, Koslowski J, Niggemann S, Jacobs G, Engelmann U, Addicks K, Bloch W.

    Cancer. 2002 Dec 1;95(11):2293-301.PMID: 12436434 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of the endothelin a receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats.

    Witte K, Reitenbach I, Stolpe K, Schilling L, Kirchengast M, Lemmer B.

    J Cardiovasc Pharmacol. 2003 Jun;41(6):890-6.PMID: 12775966 [PubMed - indexed for MEDLINE]Related articles

    19.

    Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.

    Nakane M, Kolasa T, Chang R, Miller LN, Moreland RB, Brioni JD.

    J Pharmacol Sci. 2006 Oct;102(2):231-8.PMID: 17050951 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Inactivation of soluble guanylate cyclase by stoichiometric S-nitrosation.

    Mayer B, Kleschyov AL, Stessel H, Russwurm M, Münzel T, Koesling D, Schmidt K.

    Mol Pharmacol. 2009 Apr;75(4):886-91. Epub 2008 Dec 29.PMID: 19114587 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data